Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDP167 in Mixed Dyslipidemia
NCT07799129Phase 2Not yet recruiting
- Sponsor
- Eddingpharm
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of EDP167 in mixed dyslipidemia, sponsored by Eddingpharm. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
EDP167
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT07799129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799129.